Tuesday, June 3, 2014

NEJM - Dalbavancin for Skin Infections


"Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection"
http://www.nejm.org/doi/full/10.1056/NEJMoa1310480?query=featured_home
"CONCLUSIONS
Once-weekly intravenous dalbavancin was not inferior to twice-daily intravenous vancomycin followed by oral linezolid for the treatment of acute bacterial skin and skin-structure infection,"

No comments:

Post a Comment